We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-15.26%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$7.53B
AUM Growth
-$2.75B
Cap. Flow
-$1.08B
Cap. Flow %
-14.29%
Top 10 Hldgs %
12.34%
Holding
1,547
New
122
Increased
288
Reduced
505
Closed
182

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$67.4M
2
UNP icon
Union Pacific
UNP
+$58.9M
3
LLY icon
Eli Lilly
LLY
+$58.2M
4
MKC icon
McCormick & Company Non-Voting
MKC
+$55.5M
5
PLD icon
Prologis
PLD
+$44.7M

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$86.6M
2
DINO icon
HF Sinclair
DINO
+$82.3M
3
CAT icon
Caterpillar
CAT
+$75.6M
4
FANG icon
Diamondback Energy
FANG
+$65.1M
5
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$59.8M

Sector Composition

Rank Sector Weight
1 Financials 24.04%
2 Healthcare 13.43%
3 Consumer Discretionary 11.21%
4 Industrials 10.14%
5 Technology 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SER icon
1326
Serina Therapeutics
SER
$33.3M
$72K ﹤0.01%
+684
New +$87K
MICR
1327
DELISTED
Micron Solutions, Inc.
MICR
$70K ﹤0.01%
26,425
– –
PRHI
1328
Presurance Holdings
PRHI
$18.1M
$67K ﹤0.01%
2,714
– –
AMTX icon
1329
Aemetis
AMTX
$120M
$63K ﹤0.01%
103,239
-65,000
-39% -$56.5K
PLX icon
1330
Protalix BioTherapeutics
PLX
$200M
$63K ﹤0.01%
20,259
– –
ARTW icon
1331
Arts-Way Manufacturing Co
ARTW
$11.3M
$60K ﹤0.01%
30,000
– –
TIK
1332
DELISTED
Tel-Instrument Electronics Corp.
TIK
$57K ﹤0.01%
15,000
– –
SIF icon
1333
SIFCO Industries
SIF
$172M
$55K ﹤0.01%
16,024
– –
IMDZ
1334
DELISTED
Immune Design Corp.
IMDZ
$55K ﹤0.01%
42,400
-178,792
-81% -$311K
SCPH
1335
DELISTED
scPharmaceuticals
SCPH
$54K ﹤0.01%
14,300
-55,200
-79% -$259K
CATX icon
1336
Perspective Therapeutics
CATX
$342M
$51K ﹤0.01%
16,870
-980
-5% -$4.2K
NOVN
1337
DELISTED
Novan, Inc. Common Stock
NOVN
$50K ﹤0.01%
6,000
-2,269
-27% -$46.4K
BBOX
1338
DELISTED
Black Box Corp
BBOX
$49K ﹤0.01%
45,000
– –
INTX
1339
DELISTED
Intersections, Inc.
INTX
$46K ﹤0.01%
12,500
– –
ZDGE icon
1340
Zedge
ZDGE
$38.8M
$41K ﹤0.01%
16,855
– –
ZNB
1341
Zeta Network Group
ZNB
$2.57M
– –
0
– –
ARAV
1342
DELISTED
Aravive, Inc. Common Stock
ARAV
$40K ﹤0.01%
11,500
-2,683
-19% -$15.4K
MDLY
1343
DELISTED
Medley Management Inc
MDLY
$39K ﹤0.01%
1,000
– –
NVIV
1344
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$39K ﹤0.01%
+35
New +$50.8K
SYPR icon
1345
Sypris Solutions
SYPR
$47.4M
$36K ﹤0.01%
46,404
– –
SNNA
1346
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$35K ﹤0.01%
15,200
– –
MXC icon
1347
Mexco Energy
MXC
$19.3M
$33K ﹤0.01%
12,000
– –
PZG icon
1348
Paramount Gold Nevada
PZG
$118M
$33K ﹤0.01%
40,000
– –
NH
1349
DELISTED
NantHealth, Inc
NH
$33K ﹤0.01%
+4,060
New +$71.1K
SGMA
1350
DELISTED
Sigmatron International
SGMA
$32K ﹤0.01%
13,500
– –
52 53
54
55 56

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bridgeway Capital Management held 1,547 positions worth $7.53B, down 27% from $10.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bridgeway Capital Management withdrew a net $1.08B in Q4 2018, closing 182 positions and reducing 505 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $86.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bridgeway Capital Management opened a new position in Eli Lilly worth $60.3M.

  • Bridgeway Capital Management's largest Q4 2018 buy was Eli Lilly: 521,450 shares worth $60.3M.
  • Bridgeway Capital Management added most to Merck in Q4 2018, an estimated $67.4M increase.
  • Bridgeway Capital Management's biggest Q4 2018 reduction was ON Semiconductor, cutting an estimated $54.9M.
  • Bridgeway Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $86.6M.
  • Bridgeway Capital Management's ten largest holdings make up 12% of its $7.53B portfolio in Q4 2018.
  • Bridgeway Capital Management opened 122 new positions and closed 182 in Q4 2018.
  • Bridgeway Capital Management's portfolio value fell 27% quarter-over-quarter to $7.53B.

Based on Bridgeway Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.